7 months after announcing a pivot to drug discovery, Zymergen is acquired by Ginkgo

Zymergen aimed to leave its well-publicized woes behind through a new-year transformation into a biotech. Now, the company has been picked up by Ginkgo Bioworks, which will look for “strategic alternatives” for the new drug discovery business once the sale is complete.